申请人:Matsumoto Kazuko
公开号:US20050255465A1
公开(公告)日:2005-11-17
It is intended to provide novel labeling reagents characterized by having a group capable of binding to a substance to be labeled (for example, a biological substance, a physiologically active substance, etc.), easily forming a complex together with a rare earth ion, the complex being stable in an aqueous solution, and having a sufficient fluorescence intensity and a long fluorescence life time regardless of buffer types; complexes composed of the above labeling reagent with a rare earth ion; fluorescence labels containing the above complex; a fluorescence assay method using the above fluorescent label; etc. Namely, labeling reagents comprising a compound having a 2,2′:6′,2″-tripyridine skeleton or a 2,6-dipyrazolopyridine skeleton and having a group capable of binding to a substance to be labeled (for example, a biological substance, a physiologically active substance, etc.) and a group capable of forming a complex together with a rare earth ion; complexes composed of the above labeling reagent with a rare earth ion; fluorescence labels containing the above complex; a fluorescence labeling method using the above complex as a label; and a fluorescence assay method using the above fluorescent label.
本发明旨在提供新型标记试剂,其特征在于:具有能够与待标记物质(例如生物物质、生理活性物质等)结合的基团,易于与稀土离子形成络合物,络合物在水溶液中稳定,并且具有足够的荧光强度和较长的荧光寿命,不受缓冲液类型的影响。),容易与稀土离子形成络合物,该络合物在水溶液中稳定,并具有足够的荧光强度和较长的荧光寿命,不受缓冲液类型的影响;由上述标记试剂与稀土离子组成的络合物;含有上述络合物的荧光标签;使用上述荧光标签的荧光检测方法等。也就是说,标记试剂包括具有 2,2′:6′,2″-三吡啶骨架或 2,6-二吡唑吡啶骨架的化合物,该化合物具有能够与待标记物质(例如生物物质、生理活性物质等)结合的基团,以及能够与待标记物质(例如生物物质、生理活性物质等)结合的基团。)和能够与稀土离子形成络合物的基团;由上述标记试剂与稀土离子组成的络合物;含有上述络合物的荧光标签;使用上述络合物作为标签的荧光标记方法;以及使用上述荧光标签的荧光检测方法。